Back
Speaker illustration

undefined undefined undefined

Presentations Articles

Real-world use and effectiveness of patiromer among patients with heart failure at high risk of hyperkalaemia: insights from the CARE-HK in HF registry

Event: Heart Failure 2025

Topic: Pharmacotherapy

Session: Diverse pharmacological progress in heart failure

Access
Like
Thumbnail

A national heart failure initiative is associated with improved use of quadruple guideline-directed medical therapy

Event: ESC Congress 2023

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Insights from recent HFrEF trials 2

Access
Like
Thumbnail

Panel discussion and conclusion

Event: Heart Failure 2023

Topic: Chronic Heart Failure

Session: Reducing hospitalisations and improving quality of life: why use cardiac contractility modulation (CCM)?

Access
Like
Thumbnail

CCM: what are the benefits of early implementation?

Event: Heart Failure 2023

Topic: Chronic Heart Failure

Session: Reducing hospitalisations and improving quality of life: why use cardiac contractility modulation (CCM)?

Access
Like
Thumbnail

Role of natriuretic peptides in the pre-discharge phase

Event: Heart Failure 2023

Topic: Heart Failure Association (HFA)

Session: How to use natriuretic peptides in the management of patients with heart failure

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources